Ad is loading...
ALGS
Price
$19.17
Change
-$0.29 (-1.49%)
Updated
Nov 15 closing price
RLAY
Price
$5.11
Change
-$0.49 (-8.75%)
Updated
Nov 15 closing price
95 days until earnings call
Ad is loading...

ALGS vs RLAY

Header iconALGS vs RLAY Comparison
Open Charts ALGS vs RLAYBanner chart's image
Aligos Therapeutics
Price$19.17
Change-$0.29 (-1.49%)
Volume$424.21K
CapitalizationN/A
Relay Therapeutics
Price$5.11
Change-$0.49 (-8.75%)
Volume$1.93M
CapitalizationN/A
ALGS vs RLAY Comparison Chart
Loading...
ALGS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ALGS vs. RLAY commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGS is a Sell and RLAY is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (ALGS: $19.17 vs. RLAY: $5.11)
Brand notoriety: ALGS and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALGS: 169% vs. RLAY: 98%
Market capitalization -- ALGS: $68.78M vs. RLAY: $854.49M
ALGS [@Biotechnology] is valued at $68.78M. RLAY’s [@Biotechnology] market capitalization is $854.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGS’s FA Score shows that 1 FA rating(s) are green whileRLAY’s FA Score has 1 green FA rating(s).

  • ALGS’s FA Score: 1 green, 4 red.
  • RLAY’s FA Score: 1 green, 4 red.
According to our system of comparison, ALGS is a better buy in the long-term than RLAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGS’s TA Score shows that 6 TA indicator(s) are bullish while RLAY’s TA Score has 4 bullish TA indicator(s).

  • ALGS’s TA Score: 6 bullish, 4 bearish.
  • RLAY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ALGS is a better buy in the short-term than RLAY.

Price Growth

ALGS (@Biotechnology) experienced а +88.13% price change this week, while RLAY (@Biotechnology) price change was -17.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

ALGS is expected to report earnings on Nov 06, 2024.

RLAY is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($854M) has a higher market cap than ALGS($68.8M). ALGS YTD gains are higher at: 15.482 vs. RLAY (-53.633). ALGS has higher annual earnings (EBITDA): -90.79M vs. RLAY (-367.86M). RLAY has more cash in the bank: 688M vs. ALGS (94.5M). ALGS has less debt than RLAY: ALGS (9.84M) vs RLAY (51.1M). RLAY has higher revenues than ALGS: RLAY (35.2M) vs ALGS (7.97M).
ALGSRLAYALGS / RLAY
Capitalization68.8M854M8%
EBITDA-90.79M-367.86M25%
Gain YTD15.482-53.633-29%
P/E RatioN/AN/A-
Revenue7.97M35.2M23%
Total Cash94.5M688M14%
Total Debt9.84M51.1M19%
TECHNICAL ANALYSIS
Technical Analysis
ALGSRLAY
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
87%
Aroon
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
83%
View a ticker or compare two or three
Ad is loading...
ALGS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PAGHX99.37-0.21
-0.21%
Permanent Portfolio Aggressive Growth C
LMEAX17.39-0.10
-0.57%
Franklin International Equity A
PGLEX15.83-0.14
-0.88%
Putnam Focused International Equity R6
PRVIX59.73-0.56
-0.93%
T. Rowe Price Small-Cap Value I
OSCYX24.06-0.33
-1.35%
Invesco Main Street Small Cap Y

ALGS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGS has been loosely correlated with STRO. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGS jumps, then STRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGS
1D Price
Change %
ALGS100%
-1.49%
STRO - ALGS
39%
Loosely correlated
-16.23%
RLAY - ALGS
28%
Poorly correlated
-8.84%
CNSP - ALGS
27%
Poorly correlated
-11.61%
TSHA - ALGS
27%
Poorly correlated
-9.25%
ANNX - ALGS
26%
Poorly correlated
-3.32%
More

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with XNCR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
-8.84%
XNCR - RLAY
56%
Loosely correlated
-1.83%
BCYC - RLAY
46%
Loosely correlated
-3.50%
TVTX - RLAY
45%
Loosely correlated
-4.06%
PGEN - RLAY
45%
Loosely correlated
-7.11%
ABOS - RLAY
45%
Loosely correlated
-8.05%
More